How Covid-19 could affect your life insurance

United States News News

How Covid-19 could affect your life insurance
United States Latest News,United States Headlines
  • 📰 TheCitizen_News
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 75%

Should you not have cover in place, now may be a good time to consider.

While life insurance is important during a pandemic or similar situation, you won’t find any insurer that will accept you while you have been positively diagnosed for Covid-19. The uncertainty of the illness, however, isn’t the reason you’re likely to be declined: Even before the current global pandemic, insurers would hesitate or refuse to give a policy to those with pre-existing conditions.

As Covid-19 can result in a lengthy period of illness, check whether your policy includes a temporary disability benefit for an injury or illness which leaves you unable to perform your occupation for a certain period and check whether any waiting periods apply. Age and gender, a compromised immune system, where you live, and if you smoke or not can also affect life insurance premiums. Economic fallout or adverse effects from the influx of deaths may cause insurers to reevaluate their premiums. If you have any underlying risks or problems that come up during underwriting, it will be harder for you to get a policy, or even if your family has a history of chronic illness or other serious diseases. Some policies cover common disorders like epilepsy.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

TheCitizen_News /  🏆 6. in ZA

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

COVID-19: WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce deathCOVID-19: WHO halts hydroxychloroquine, HIV drugs in COVID trials after failure to reduce deathGENEVA, July 4 (Reuters) - The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with COVID-19 after they failed to reduce mortality.
Read more »

THE CONVERSATION: Civil society groups that mobilised around COVID-19 face important choicesTHE CONVERSATION: Civil society groups that mobilised around COVID-19 face important choicesAs the Covid-19 crisis drags on and evolves, civil society activist groups are responding to growing and diversifying needs, just when access to resources is becoming more insecure for many of them. Activists face some tough choices around how to keep going, what to focus on, and how to achieve longer-term impacts.
Read more »

Nigerian doctors face onslaught from security forces during Covid-19 battleDoctors report that incidents of extortion, beatings and arbitrary detention have rocketed
Read more »

Covid-19: Traumatised family say they were given wrong body to buryA family from Uitenhage is traumatised after being given the wrong body by authorities who they thought had merely made a spelling error. They were subsequently contacted by their priest who broke the news that they had buried the wrong man. SundayIndy
Read more »

Covid-19 blowing Africa's HIV fight off track — expertsIf the Covid-19 related disruptions to HIV programmes continue unabated for another six months, mother-to-child transmission of HIV will be set back a decade.
Read more »



Render Time: 2025-03-09 19:30:52